Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634–653
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP (2012) Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54(Suppl 1):S23–S34
Petrikkos G, Skiada A, Lortholary O et al (2012) Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54:S23–S34
Edeas M, Saleh J, Peyssonnaux C (2020) Iron: innocent bystander or vicious culprit in COVID-19 pathogenesis? Int J Infect Dis 97:303–305
Sharma S, Grover M, Bhargava S, Samdani S, Kataria T (2021) Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol, 1–6
Cavezzi A, et al (2020) COVID-19: hemoglobin, iron, and hypoxia beyond inflammation: a narrative review. Clin Pract
Spellberg B, Edwards J Jr, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18:556–569
Moorthy A, Gaikwad R, Krishna S, Hegde R, Tripathi KK, Kale PG, Rao PS, Haldipur D, Bonanthaya K (2021) SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective multi-centric analysis. J Maxillofac Oral Surg 6:1–8
John TM, Jacob CN, Kontoyiannis DP (2021) When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi 7:298
Guan W-J, Ni Z-Y, Hu Y, Liang W-h, Ou C-Q, He J-X et al (2020) Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv
Antinori S, Nebuloni M, Magni C, Fasan M, Adorni F, Viola A, Corbellino M, Galli M, Vago G, Parravicini C et al (2009) Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1630 autopsies performed between 1984 and 2002. Am J Clin Pathol 132:221–227
Bouchara JP, Oumeziane NA, Lissitzky JC, Larcher G, Tronchin G, Chabasse D (1996) Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components. Eur J Cell Biol 70(1):76–83
Koparal M, Kurt E, Altuntas EE, Dogan F (2021) Assessment of mucociliary clearance as an indicator of nasal function in patients with COVID-19: a cross-sectional study. Eur Arch Otorhinolaryngol 278(6):1863–1868
Çeçen A, Bayraktar C, Özgür A, Akgül G, Günal Ö (2021) Evaluation of nasal mucociliary clearance time in COVID-19 patients. J Craniofacial Surg: April 29, 2021—volume Publish Ahead of Print - Issue
Chang D, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, Sharma L (2020) Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA
Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, Fontanet A, Bretagne S, Dromer F; French Mycosis Study Group (2014) Worrisome trends in incidence and mortality of candidemia in intensive care units [Paris area, 2002–2010]. Intensive Care Med 40(9): 1303–1312
Gebremariam T, Lin L, Liu M et al (2016) Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis. J ClinInvest 126:2280–2294
Spellberg B, Andes D, Perez M, Anglim A, Bonilla H, Mathisen GE et al (2009) Safety and outcomes of openlabel deferasirox iron chelation therapy for mucormycosis. Antimicrob Agents Chemother 53(7):3122–3125
Oriot P, Hermans MP (2020) Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature. Acta Clin Belg
Smith SM, Boppana A, Traupman JA, Unson E, Maddock DA, Chao K, Dobesh DP, Brufsky A, Connor RI (2021) Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19. J Med Virol 93(1):409–415
Wu L, Girgis CM, Cheung NW (2020) COVID-19 and diabetes: insulin requirements parallel illness severity in critically unwell patients. Clin Endocrinol 93:390–393
Gianchandani R et al (2020) Managing hyperglycemia in the COVID-19 inflammatory storm. Diabetes 69:2048–2053
Pal R, Banerjee M, Yadav U, Bhattacharjee S (2020) Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: a systematic review of literature. Diabetes Metab Syndr 14:1563–1569
Potier L et al (2020) COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes. Diabetes Metab
Marchand L, Pecquet M, Luyton C (2020) Type 1 diabetes onset triggered by COVID-19. Acta Diabetol 57:1265–1266
Yang JK, Lin SS, Ji XJ, Guo LM (2010) Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 47(3):193–199
Min KH, Rhee CK, Jung JY, Suh MW (2012) Characteristics of adverse effects when using high dose short term steroid regimen. Korean J Audiol 16(2):65–70
Howard DH (1999) Acquisition, transport, and storage of iron by pathogenic fungi. Clin Microbiol Rev 12:394–404
Artis WM, Fountain JA, Delcher HK, Jones HE (1982) A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 31:1109–1114
Majeed A, Shajar MA (2020) Is hemoglobin the missing link in the pathogenesis of COVID-19? Anaesth Pain Intensive Care 24:9–12
Chen C, et al (2020) Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies, Chin. J Burns
Colafrancesco et al (2020) COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? Autoimmunity reviews
Merad M, Martin J (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. /https://doi.org/10.1038/S41577-020-0331-4
Perricone C, Bartoloni E, Bursi R, Cafaro G, Guidelli GM, Shoenfeld Y, Gerli R (2020) COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res 68:213–224
Pretorius E, Kell D (2014) Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integr Biol [Camb]
Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endothelitis in COVID-19. Lancet 395:1417–1418
Ehsani S (2003) Distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein: a potential hint at the possibility of local iron dysregulation in COVID-19. arXiv: 2003
Hirschhorn T, Stockwell BR (2019) The development of the concept of ferroptosis. Free Radic Biol Med 133:130–143
Shirazi F, Kontoyiannis DP, Ibrahim AS (2015) Iron starvation induces apoptosis in Rhizopus oryzae in vitro. Virulence 6:121–126
Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR et al (2012) The deferasirox- AmBisome therapy for mucormycosis [DEFEAT Mucor] study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 67(3):715–22
Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW et al (2007) The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 117(9):2649
Baldin C, Ibrahim AS (2017) Molecular mechanisms of mucor- mycosis—the bitter and the sweet. Sheppard DC, ed. PLOS Pathog 13: e1006408
Gebremariam T, Liu M, Luo G, Bruno V, Phan QT, Waring AJ, Edwards JE, Filler SG, Yeaman MR, Ibrahim AS (2014) CotH3 mediates fungal invasion of host cells during mucormycosis. J Clin Investig 124:237–250
Ibrahim IM, Abdelmalek DH, Elfiky AA (2019) GRP78: a cell’s response to stress. Life Sci 226:156–163
Ibrahim IM, Abdelmalek DH, Elshahat ME, Elfiky A (2020) COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect 8:554–562
Fu J, Wei C, He J, Zhang L, Zhou J, Balaji KS, Shen S, Peng J, Sharma A, Fu J (2021) Evaluation and characterization of HSPA5 [GRP78] expression profiles in normal individuals and cancer patients with COVID-19. Int J Biol Sci 17(3):897–910
Belyamani L, Ibrahimi A (2020) Targeting the GRP78-dependant SARS-CoV-2 cell entry by peptides and small molecules. Bioinform Biol Insights 21(14):11
Liu M, Spellberg B, Phan QT et al (2010) The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest 120:1914–1924
Kalongi Y, Mwanza K, Tshisuaka M, Lusiama N, Ntando E, Kanzake L, Rollin P (1999) Isolated case of ebola hemorrhagic fever with mucormycosis complications, Kinshasa, Democratic Republic of the Congo. J Infect Dis 179:, S15-S17
Ahmadikia K, Hashemi SJ, Khodavaisy S et al (2021) The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Mycoses 00:1–11
Sabirli R, Koseler A, Goren T, Turkcuer I, Kurt O (2021) High GRP78 levels in Covid-19 infection: a case-control study. Life Sci 265: 118781
Bellanger AP, Tatara AM, Shirazi F et al (2016) Statin concentrations below the minimum inhibitory concentration attenuate the virulence of Rhizopus oryzae. J Infect Dis 214:114–121
Reed C, Bryant R, Ibrahim AS et al (2008) Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 47:364–371
Garg D, Muthu V, Sehgal IS et al (2021) Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 186:289–298